We are focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.See Our Pipeline Get In Touch
The current medicine landscape is dominated by “classic” small molecules (drugs created in a lab using traditional drug discovery techniques). While traditional medicines, including small molecule medicines, provide a great benefit to populations, they need to have a well-defined structure to be effective therapies. As such, the scientific community has turned to what we now refer to as Biologics.
Biologics are larger molecule medicines that are produced by genetically engineering microorganisms to produce specific proteins. The benefit with larger molecule drugs, specifically biologics, is that they can exert their effects on a broader spectrum of targets.